8-KThe WireStrategic
Material Agreement · Bylaw Amendment
Filed Jul 19, 2023 · 2y ago · Accession 0001213900-23-058024
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Estrella Immunopharma, Inc.
- Ticker
- ESLAW
- CIK
- 1844417
- Form type
- 8-K
- Filing date
- Jul 19, 2023
- Report date
- Jul 17, 2023
- Document
- ea181964-8k_tradeupacq.htm
- Size
- 314 KB